The global pandemic of non-vector borne environmental diseases may, in large part, be attributed to chronic exposures to ever increasing levels of exogenous lipophilic chemicals. These chemicals include persistent organic pollutants, semi-volatile compounds and low molecular weight hydrocarbons. Such chemicals facilitate the sequential absorption of otherwise not absorbed more toxic hydrophilic species that attack numerous body organs and systems, leading to environmental disease. Co-morbidities of noncommunicable environmental diseases are alarmingly high, with as many as half of all individuals chronically ill with two or more diseases. Co-morbidity is to be anticipated, since all of the causative chemicals identified have independently been shown to trigger the individual diseases.
Introduction
The prevalence of non-vector borne environmental disease in the world has reached pandemic proportions (Murray et al., 2012) . In the United States alone, half of all adults have at least one environmental disease and more than a quarter of the adult population suffers from two or more co-morbid environmental diseases (Bauer et al., 2014; Jakovljevic et al., 2013; van Oostrom et al., 2012) . Indeed, rapid increases in incidences of environmental diseases have not been limited to the industrialized areas of the globe but have also spread to remote areas including those inhabited by indigenous populations in the tropics and near the poles . The rapid rise in the prevalence of these diseases can only be linked to environmental effects (Boyle et al., 2010) . A common thread in many environmental diseases is the presence of exogenous lipophilic toxic chemicals in the bodies of those affected (Zeliger, 2013; Zeliger, 2013a; Zeliger 2013b) .
It has been previously reported that chemically sensitive individuals exposed to low molecular weight hydrocarbons (LMWHCs) had numerous co-morbidities . It can now be reported that exposures act as solvents and carriers for impermeable hydrophiles to facilitate absorption of species which would not otherwise permeate through the cells' lipophilic barriers (Zeliger 2003) .
It has also been previously shown that mixtures of toxic lipophilic and hydrophilic species produce enhanced toxicities, low-level effects and attacks on organs and/ or systems not known to be impacted by either species alone (Zeliger, 2003; Zeliger, 2011) . Such effects have been observed following simultaneous exposures to mixtures of lipophililc and hydrophilic chemicals. Environmental disease can be triggered by the initial absorption and retention of lipophilic species followed by the sequential uptake of hydrophilic species that then act together as a toxic mixture, with the absorption of different hydrophiles accounting for the onset of different diseases Zeliger, 2013; Zeliger, 2013a; Zeliger 2013b) .
Though different diseases involve attacks on widely disparate organs and systems, co-morbidity rates are high when individuals are exposed to environmental lipophilic toxins . The onsets of co-morbid diseases do not follow set patterns. Published studies show that individuals with two co-morbid diseases, e.g., T2D and hypertension, are just as likely to become ill with one first as the other first (Sowers et al., 2001) , for example. The wide prevalence of co-morbid environmental diseases and the lack of a pattern of onset strongly suggests the common cause for these diseases that has been previously reported on (Zeliger, 2013; Zeliger, 2013a; Zeliger, 2013b) .
Methods
The results presented here are based upon a literature review of numerous studies on the toxic effects of the chemicals on the body. These studies include epidemiological and case studies. Adverse effects on health were in all instances diagnosed by appropriate clinical examinations. Data for pairs of co-morbidities were carried out by literature searches for the words, "co-morbidity" and the names of the two diseases, "cardiovascular disease" and "musculoskeletal disease", for example.
Results
Specific lipophilic chemicals associated with multiple environmental diseases include those previously reported to be associated with T2D, cardiovascular disease and neurological disease. These include non-volatile POPs, semi-volatile and volatile species (Zeliger, 2013; Zeliger, 2013a; Zeliger, 2013b) .
Major environmental diseases that have been associated with lipophilic exposure include immunological, neurological, neurodegenerative reproductive, cardiovascular, metabolic, musculoskeletal and carcinogenic ones. These are listed in Table 1 .
All of the diseases listed in Table 1 are co-morbid with other environmental diseases that are known to be triggered by exposures to lipophilic chemicals. Figure 1 shows the co-morbidities of the 11 types of these diseases with each other. Table 2 lists co-morbid disease pairs and the references for these. It is of note that of the 55 binary combinations possible, 45 (82%)% have been shown to be co-morbid to date.
Discussion
The environmental diseases reported here are late onset diseases that generally follow decades of living during which physiological breakdown of many systems occur (Wright et al., 2002) . All are triggered by a combination of genetic susceptibility and environmental exposure (Zhang et al., 2010) . Several mechanisms have been proposed the account for such breakdowns. These include: oxidative stress (Uttara et al., 2009; Bolanos et al., 2009) ; epigenetic effects (Jakovcevski et al., 2012; Urdinguio et al., 2009; Baccarelli et al., 2009) ; low intensity inflammation (Miller et al., 2008; Leonhard et al., 2006; ) ; and endocrine disruption (Weiss, 2012; Mostafalou et al., 2013; Colborn et al., 
Co-morbidities of chemically induced environmental diseases. References for co-morbidity disease pairs are contained in Table  2 . X denotes the existence of co-morbidity between the two diseases. 1997). One theory of co-morbidities of environmental diseases is that there are phenotype connections between diseases, i.e., that patients are affected by diseases that are connected to other diseases by a Phenotype Disease Network (Hidalgo et al., 2009; Zhang et al., 2010; . All of these theories are consistent with what is reported here, since exposures to all the lipophilic chemical types described above (POPs, semi-volatile organic compounds, and volatile organic compounds) have been independently been associated with each of the diseases listed in Table 1 (Zeliger, 2013; Zeliger, 2013a; Zeliger, 2013b) . It is beyond the scope of this paper to examine these mechanisms in detail. Readers are directed to the references cited for elaboration. Since all of the diseases listed in Table 1 have been related to exogenous lipophilic adsorption (Zeliger, 2013; Zeliger 2013a; Zeliger 2013b ) it is to a great extent predictive that individuals ill with one of these diseases will be co-morbidly ailing with at least one other of these diseases . This can be stated emphatically, as there are numerous studies in the literature showing, that where individuals are co-morbid with two of these diseases, the co-morbidities are independent of the order of onset of the two diseases, i.e., that either of the diseases can precede the other. The following serve as examples of these studies. Somers et al. reported that individuals with autoimmune disease show higher than expected co-morbidities with musculoskeletal disease and type 2 diabetes and that in both instances either of the diseases could precede the other (Somers et al., 2009) . In people co-morbid with metabolic syndrome and mental health disorders, either condition can precede the other (Nousen et al., 2013) . Obesity and depression are common comorbid conditions and either one can precede the other (Luppino et al., 2012) . Hypertension is about twice as common in diabetics as in those without diabetes and either disease can precede the other (Sowers et al., 1995; Sowers et al., 2001) .
Based on the above, it can be stated that one cause of numerous environmental diseases and co-morbidities is chronic lipophilic exposure to lipophiles such as persistent organic pollutants (POPs), semi-volatile exogenous chemicals (SVOCs) and low molecular weight hydrocarbons (LMWHCs). Examples of POPs are polychlorinated biphenyls (PCBs) and organochlorine pesticides (OCs). Examples of semi-volatile compounds are bisphenol A, phthalates and polynuclear aromatic hydrocarbons. Examples of volatile organic compounds are 8 carbon or less aliphatic and single-chain aromatic hydrocarbons. POPs are slowly metabolized and eliminated and
Disease Pair References
T2D -CVD Sowers et al., 1995; Colosia et al., 2013; Mannino et al., 2008; Struijs et al., 2006; Sowers et al., 2001; Ramakrishnan et al., 2013. T2D -NRD Blackman et al., 2013; Sowers et al., 1995; Uzun et al., 2009; Katon, 2008; Struijs et al., 2006; . T2D -NDV Kohane et al., 2012 . T2D -NDG Bannon, 2002 Duthie et al., 2011; Gage et al., 2003; Struijs et al., 2006 . T2D -MSK Al-Bishri et al., 2013 Mannino et al., 2008; Slater et al., 2011 . T2D -IMM Somers et al., 2009 T2D -RES van der Molen, 2010; Varela et al., 2013; Cazzola et al., 2013; Mannino et al., 2008; Struijs et al., 2006; Chatila et al., 2008 . T2D -CMS Zeliger et al., 2012 . T2D -OBS Colosia et al., 2013; Sowers et al., 2001; Khaodhiar et al., 1999 . T2D -CAN Habib et al., 2013 van Baal et al., 2011 . CVD -NRD McIntyre et al., 2008 Uzun et al., 2009; Larsen et al., 2009 . CVD -NDV Tyler et al., 2011 . CVD -NDG Armon, 2004 Bannon, 2011; Duthie et al., 2011; Zamrini et al., 2004; Gage et al., 2003; Perju-Dumbrava et al., 2014 . CVD -MSK Al-Bishri et al., 2013 Slater et al., 2011; Hudon et al., 2008 . CVD -IMM Marrie et al, 2013 Aaron et al., 2000. CVD -RES Karlstad et al., 2012; van der Molen, 2010; Varela et al., 2013; Chatila et al., 2008 . CVD -CMS Zeliger et al., 2012 . CVD -OBS Sowers et al., 2001 Khaodhiar et al., 1999 . CVD -CAN Kreatsoulas et al., 2014 Sorensen, 2013 . NRD -NDV Cristino et al., 2013 Simonoff et al., 2008; Jensen et al., 2014 . NRD -NDG Varela et al., 2013 Gage et al., 2003 .
Disease Pair
References NRD -MSK Marrie et al., 2013; Blackman et al., 2013; McIntyre et al., 2008; Hudon et al., 2008 . NRD -IMM Marrie et al., 2013 Aaron et al., 2001 . Karlstad et al., 2012; Blackman et al., 2013; van der Molen, 2010; McIntyre et al., 2008; Cazzola et al., 2013; Chatila et al., 2008 . NRD -CMS Zeliger et al., 2012 NRD -OBS McIntyre et al., 2008 Khaodhiar et al., 1999; Luppino et al., 2010 . NDV -RES Fasmer et al., 2011 . NDV -OBS Suren et al., 2014 . NDV -CAN Crespi, 2011 . NDG -MSK Gage et al., 2003 . NDG -CAN Crespi, 2011 Zamrini et al., 2004; Gage et al., 2003 MSK -IMM Somers et al., 2009 Ciccone et al., 2003. MSK -RES van der Molen, 2010; Slater et al., 2011; Chatila et al., 2008; Hudon et al., 2008 . MSK -CMS Zeliger et al., 2012 MSK -OBS Khaodhiar et al., 1999 Hudon et al., 2008; MSK -CAN Sorensen, 2013 . IMM -RES Karlstad et al., 2012; Pinart et al., 2014 . IMM -CMS Zeliger et al., 2012 Ziem et al., 1995; Jason et al., 2000 . RES -CMS Zeliger et al., 2012 Caress et al., 2005 . Cazzolam et al., 2013; Jung et al., 2014 . Varela et al., 2013; Sorensen, 2013 . Zeliger et al., 2012 . CMA -CAN Zeliger et al., 2012 OBS -CAN Khaodhiar et al., 1999 .
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Abbreviations: T2D -type 2 diabetes; CVD -cardiovascular disease; NRD -neurological disease; NDV -neurodevelopmental disease; NDG -neurodegenerative disease; MSK -musculoskeletal disease; IMM -immunological disease; RES -respiratory disease; CMS -chemical sensitivity; OBS -obesity; CAN -cancer are stored in white adipose tissue, from where they are slowly released into the blood stream. SVOCs are more rapidly metabolized and eliminated andLMWHCs are very rapidly metabolized and eliminated, but continued exposure to SVOCs and LMWHCs leads to continuous levels in the blood as well. A steady state of lipophilic load is in effect in the body, and since lipophiles facilitate the absorption of hydrophiles, a body containing high levels of lipophiles is more likely to absorb toxic levels of hydrophiles when exposure to these occurs than one with low levels of lipophiles. This is shown by the dose-response relationships for the onset of T2D, cardiovascular disease and neurological disease (Cortu et al., 2007; Lee et al., 2006; Zeliger, 2013a; Zeliger, 2013b) . As a wide variety of exogenous lipophiles have been shown to cause all of the diseases in Table 1 , it is total exogenous lipophilic load, regardless of chemical species, that is more predictive of the onset of disease than single chemical considerations. Further credence to the theory just proposed is provided by the following considerations:
1. Not only do exogenous lipophiles cause these diseases, but one of these diseases, obesity has also been shown to cause the absorption of lipophiles (See below). 2. One in four individuals with one of these diseases is likely to be stricken with at lease one more of these diseases (Bauer et al., 2014; Jakovljevic et al., 2013; van Oostrom et al., 2012) . 3. Eleven (11) types of environmental diseases are listed in Table 1 . Of the 55 binary combinations of diseases possible, 45 (82%), have been shown to be co-morbid (see Figure 1 ). 4. All the diseases in Table 1 are late-onset ones, coming mostly after decades of exposures (Fortin et al., 2005) .
A consideration of obesity is in order here. Body Mass Index (BMI) of 30 or greater is considered obese (Luppino et al., 2010) . BMI is a predictor of human adipose tissue concentration of POPs (Vaclavik et al., 2006) . This is consistent with the fact that obesity is usually associated with CVS, T2D and other diseases, as adipose tissue releases the lipophiles it holds to the blood stream. Obesity is itself caused by POPs, phthalates, bisphenol A and other exogenous lipophiles (Dirinick et al., 2014; Choi et al., 2014; Langer et al., 2014; Lee et al., 2014; Simmons et al., 2014; Lee et al., 2011a) . Being obese and having high serum endogenous lipophiles (cholesterol and tryglycerides) contributes to the absorption of these exogenous lipophiles (Wang et al., 2007; Vaclavik et al., 2006) . This sets up what is termed here as the Obesity (OBS) -Lipophile (LIP) -Disease (DIS) triangle:
OBS
LIP DIS
Obesity causes the absorption of toxic lipophiles which in turn cause disease. Toxic lipophiles cause obesity which in turn causes the further absorption of lipophiles which cause disease. Disease causes obesity which causes the absorption of lipohiles which in turn causes further disease. (Dirinick et al., 2014; Choi et al., 2014; Langer et al., 2014; Lee et al., 2014; Simmons et al., 2014) .
Finally, it is not implied that lipophilic exposure is the only cause for environmental disease. For example, heavy metals (including arsenic, cadmium, chromium, cobalt, copper, mercury and nickel) are known trigger environmental diseases, including type 2 diabetes, cardovascular diseases and neurological diseases (Carocci et al., 2014; Caciari et al., 2013; Kuo et al., 2013; Baccarelli et al., 2009; Khan, et a., 2014; Agarwal et al., 2011; Mates et al., 2010) .
Conclusions
In conclusion, it has been previously shown that chemically sensitive individuals had numerous co-morbidities when exposed to LMWHCs . It can now be stated that exposures to all exogenous lipophiles (POPs and SVOCs, as well as LMWHCs) also produce comorbidities of environmental diseases in all segments of the population. Exposures to lipophiles result in numerous co-morbid disease pairs affecting widely differing organs and systems. It is theorized that all chronic exposures to lipophilic exogenous chemicals lead to steady states of such compounds in human blood and can cause of a wide range of environmental diseases that affect numerous body organs and systems. Since the lipophiles serve are carriers for the sequential absorption of more toxic hydrophiles, disease onset is dictated not by the individual chemistries of the lipophiles, but by total lipophilic load in the blood. Lipophilic exposure promotes obesity, which promotes the absorption of additional exogenous lipophiles that promote further environmental disease. An obesity-lipophile-disease triangle which promotes the furthering of environmental disease is thus defined.
